AAA

ABERA BIOSCIENCE AB

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪59.80 M‬SEK
−0.52SEK
‪−16.72 M‬SEK
Beta (1Y)
0.07

About ABERA BIOSCIENCE AB


CEO
Maria Alriksson
Headquarters
Uppsala
Founded
2012
ISIN
SE0015245097
FIGI
BBG00YYC17M0
Abera Bioscience AB engages in the research and development of pharmaceutical products. Its project includes Vaccine and Pneumococcal Vaccine. The company was founded by Joen Luirink on November 3, 2012 and is headquartered in Uppsala, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Analyze a symbol's price movements over past years with our seasonal tools, helping you spot repeating annual trends and better gauge potential market patterns.

Frequently Asked Questions


The current price of ABERA is 3.84 SEK — it has decreased by −0.26% in the past 24 hours. Watch ABERA BIOSCIENCE AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange ABERA BIOSCIENCE AB stocks are traded under the ticker ABERA.
ABERA stock has fallen by −1.79% compared to the previous week, the month change is a 0.26% rise, over the last year ABERA BIOSCIENCE AB has showed a −4.48% decrease.
ABERA reached its all-time high on Sep 9, 2021 with the price of 35.20 SEK, and its all-time low was 3.05 SEK and was reached on Jun 12, 2023. View more price dynamics on ABERA chart.
See other stocks reaching their highest and lowest prices.
ABERA stock is 0.26% volatile and has beta coefficient of 0.07. Track ABERA BIOSCIENCE AB stock price on the chart and check out the list of the most volatile stocks — is ABERA BIOSCIENCE AB there?
Today ABERA BIOSCIENCE AB has the market capitalization of ‪59.80 M‬, it has decreased by −3.97% over the last week.
Yes, you can track ABERA BIOSCIENCE AB financials in yearly and quarterly reports right on TradingView.
ABERA BIOSCIENCE AB is going to release the next earnings report on Nov 7, 2024. Keep track of upcoming events with our Earnings Calendar.
ABERA earnings for the last quarter are −0.04 SEK per share, whereas the estimation was 0.01 SEK resulting in a −500.00% surprise. The estimated earnings for the next quarter are −0.13 SEK per share. See more details about ABERA BIOSCIENCE AB earnings.
ABERA BIOSCIENCE AB revenue for the last quarter amounts to 0.00 SEK, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ABERA net income for the last quarter is ‪−665.00 K‬ SEK, while the quarter before that showed ‪−359.00 K‬ SEK of net income which accounts for −85.24% change. Track more ABERA BIOSCIENCE AB financial stats to get the full picture.
No, ABERA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ABERA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABERA BIOSCIENCE AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABERA BIOSCIENCE AB technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABERA BIOSCIENCE AB stock shows the sell signal. See more of ABERA BIOSCIENCE AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.